Policy & Ethics

A few weeks ago, our Board of Scientific Advisor Susan Goldhaber wrote about a better way to determine the toxicity of compounds than using animal studies. A scient

The review, summarized in the CDC Moving Forward Summary Report, is just the beginning of their institutional soul-searching.

Over the last few years, enrollment in Medicare Advantage has grown significantly; nearly half of Medicare beneficiaries now belong to one of the 43 plans available. Why not?

Of course, the downside with relying on naturally acquired immunity (and forgoing vaccination) – is that you must first get COVID. But now that there’s Paxlovid, who cares? Right?

The article begins with a bit of hyperbole in explaining the $2.5 billion spent on social determinants of health (SDOH),

It's easy for politicians to make speeches or for cities, towns, and sports teams to put together a tribute to our veterans.

Conspiracy theories are dan

Dr. Oster makes several key points.

Responding to medical experts, including the American Medical Association, who have been complaining for ye